RaySearch Laboratories AB (publ) (LON:0GRZ)

London flag London · Delayed Price · Currency is GBP · Price in SEK
219.50
+1.00 (0.46%)
At close: Dec 19, 2025
7.07%
Market Cap621.81M
Revenue (ttm)101.97M
Net Income (ttm)17.31M
Shares Outn/a
EPS (ttm)0.50
PE Ratio35.93
Forward PE30.01
Dividend0.23 (0.11%)
Ex-Dividend DateMay 23, 2025
Volume14,194
Average Volume8,528
Open222.00
Previous Close218.50
Day's Range219.50 - 225.00
52-Week Range198.20 - 369.50
Beta1.21
RSI42.43
Earnings DateFeb 12, 2026

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation... [Read more]

Industry Prepackaged Software
Founded 2000
Employees 416
Stock Exchange London Stock Exchange
Ticker Symbol 0GRZ
Full Company Profile

Financial Performance

In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.

Financial numbers in SEK Financial Statements

News

There is no news available yet.